MedPath

四川省仁德制药有限公司

Ownership
-
Established
1999-10-29
Employees
-
Market Cap
-
Website
http://www.sccrd.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Repaglinide

Product Name
瑞格列奈
Approval Number
国药准字H20123254
Approval Date
Jul 12, 2022
NMPA

更年灵胶囊

Approval Number
国药准字Z20043229
Approval Date
Nov 11, 2021
NMPA

元胡止痛胶囊

Approval Number
国药准字Z20064325
Approval Date
Jun 23, 2021
NMPA

银黄颗粒

Approval Number
国药准字Z20055239
Approval Date
Jan 21, 2021
NMPA

当归南枣颗粒

Approval Number
国药准字Z20063354
Approval Date
Nov 19, 2020
NMPA

石淋通颗粒

Approval Number
国药准字Z51021469
Approval Date
Aug 5, 2020
NMPA

熊胆粉

Approval Number
国药准字Z10970112
Approval Date
Jun 30, 2020
NMPA

心安胶囊

Approval Number
国药准字Z20054506
Approval Date
Jun 17, 2020
NMPA

肝速康胶囊

Approval Number
国药准字Z20033135
Approval Date
Jun 17, 2020
NMPA

熊胆胶囊

Approval Number
国药准字Z19983153
Approval Date
Jun 17, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.